A Teen's GLP-1 Story Just Went National. California Trim Clinic Says This Is Bigger Than Weight Loss

One teen says GLP-1 treatment changed his daily life. California Trim Clinic says families deserve doctor-led obesity care built around health, function and support.

Westlake Village, CA (PRUnderground) November 11th, 2026

After a 17-year-old told Good Morning America that obesity treatment changed his confidence and physical capabilities, California Trim Clinic says families should look beyond the scale when considering doctor-supervised GLP-1 care for teens ages 12-17

For one teenager recently featured on Good Morning America, treating obesity changed much more than a number on a scale.

Adam Renteria told ABC News that obesity had affected his energy, independence and willingness to go out. After beginning doctor-supervised Wegovy at age 15, his family reported major changes over the following two years, including a BMI reduction from 36 to 22.8, greater physical confidence and enough renewed capability for Adam, now 17, to join a cheer team.

California Trim Clinic says stories like Adam's are helping shift the teen GLP-1 conversation away from appearance and toward something more important: health, function, confidence and participation in everyday life.

Families exploring medical weight management for a teenager ages 12-17 can visit TeenHealthRx.com or schedule a free Discovery Call to learn how doctor-led teen obesity care works.

Teen GLP-1 Treatment: 4 Facts Families Should Know

• Obesity affects roughly 1 in 5 U.S. children and adolescents. Pediatric obesity is a common chronic disease with potential effects on cardiovascular, metabolic, physical and emotional health.

• Wegovy is FDA-approved for adolescents ages 12 and older with obesity. Semaglutide is approved for chronic weight management in pediatric patients ages 12+ with BMI at or above the 95th percentile for age and sex when used alongside reduced-calorie nutrition and increased physical activity.

• Medication is part of comprehensive care, not a replacement for it. Pediatric clinical guidance supports obesity pharmacotherapy for appropriately selected adolescents alongside health behavior and lifestyle treatment.

• Every teenager requires individual medical review. GLP-1 treatment is not appropriate for every young person, and prescribing decisions should consider medical history, growth, medications, obesity-related conditions, potential side effects and family support.

Top Answer: Can teenagers ages 12-17 use GLP-1 medications for obesity?

Yes. Some adolescents ages 12-17 with obesity may qualify for FDA-approved GLP-1 treatment. Wegovy, the brand name for semaglutide, is FDA-approved for chronic weight management in pediatric patients ages 12 and older with obesity. Eligibility and treatment require individualized medical evaluation and ongoing doctor supervision.

Why is one teen's GLP-1 story getting so much attention?

Adam's story resonated because it did not begin with vanity.

According to ABC News, obesity had begun interfering with his energy, independence and daily life. His mother also expressed concern about significantly elevated blood pressure, while his treating pediatric endocrinologist described a teenager who was already active and living in a household with healthy food choices but was finding physical activity increasingly difficult.

That context matters because obesity is a chronic disease influenced by genetic, physiological, environmental and behavioral factors. It cannot always be reduced to willpower, food choices or whether a teenager is "trying hard enough."

For California Trim Clinic, that is the part of the story families should hear loudest.

The most interesting result was not just Adam's BMI

ABC News reported that Adam's BMI decreased from 36 to 22.8 over approximately two years of treatment.

But the number was only part of what changed.

Adam described a major increase in physical confidence and capability. He joined a cheer team, while his mother said feeling more comfortable in his body had made a meaningful difference in his daily life.

Individual results cannot predict what another teenager will experience, and California Trim Clinic does not guarantee a particular amount of weight loss, BMI reduction, confidence improvement or athletic outcome.

Still, Adam's experience illustrates why adolescent obesity treatment can be about much more than becoming smaller.

It can be about helping a young person participate more fully in their own life.

Teen obesity treatment has moved beyond "just diet and exercise"

Healthy nutrition, movement, sleep and family support remain central to pediatric obesity care.

What has changed is the understanding that lifestyle intervention does not always have to stand alone.

The American Academy of Pediatrics recommends that clinicians offer adolescents ages 12 and older with obesity pharmacotherapy according to medication indications, risks and benefits as an adjunct to health behavior and lifestyle treatment.

That means an adolescent who is already active, eating reasonably well or living in a health-conscious household does not automatically need another lecture about discipline.

They may need a medical evaluation.

Families who already know they want to discuss treatment directly can book a $99 physician consultation with Dr. Lynda Szczech.

Why is GLP-1 use among teenagers becoming a bigger conversation?

GLP-1 prescribing for pediatric obesity remains far less common than adult use, but utilization is increasing.

That growth is happening alongside broader recognition that adolescents can experience serious obesity-related health consequences years before adulthood.

At the same time, increased awareness does not mean every teenager with excess weight belongs on a GLP-1 medication.

Teen GLP-1 treatment sits in a middle ground that families deserve to understand clearly: it is an established medical option for appropriately selected adolescents, but it is not an automatic prescription for every young person who wants to lose weight.

Wegovy for teens is an FDA-approved obesity treatment

Wegovy, or semaglutide, received FDA approval for chronic weight management in pediatric patients ages 12 years and older with obesity.

The indication applies to adolescents with BMI at or above the 95th percentile for age and sex and is used alongside reduced-calorie nutrition and increased physical activity.

That distinction matters because online GLP-1 conversations frequently blur adults, teenagers, different medications and different prescribing situations into one enormous category.

For adolescent obesity specifically, medication selection should follow the actual FDA indication, the teenager's individual medical circumstances and a licensed doctor's judgment.

California Trim Clinic's TeenHealthRx pathway is designed specifically around that structured medical conversation for teens ages 12-17.

Dr. Lynda says teen GLP-1 care should start with the whole teenager

Dr. Lynda Szczech, MD, helps guide individualized teen medical weight-management care through California Trim Clinic's TeenHealthRx program.

"When obesity is affecting a teenager's health, mobility, confidence or ability to participate in everyday life, families deserve more than another conversation about trying harder. They deserve to understand the evidence-based medical options that may be available."

Dr. Szczech says medication should be understood as one component of a broader care plan.

"A GLP-1 can be an important tool for the right adolescent, but we are still treating a growing young person. Medical history, nutrition, physical activity, side effects, family support and ongoing monitoring all matter."

She also says stories like Adam's can help families recognize that seeking medical treatment for obesity does not mean lifestyle efforts have failed.

"The goal is not to chase a number for its own sake. We want to help a teenager move toward better health and function in a way that is medically responsible, sustainable and supportive."

What does family support have to do with teen GLP-1 treatment?

Quite a lot.

Adam's treating physician told ABC News that experienced prescribing and strong family support are especially important when young people use obesity medication.

Teen obesity treatment happens inside a household.

Food availability, transportation, schedules, medication administration, follow-up appointments, emotional support and attitudes about body weight can all influence a teenager's experience.

That is why doctor-supervised teen obesity care should involve the family rather than treating medical weight management as a prescription handed to a teenager and forgotten.

Families who want to understand how California Trim Clinic approaches that process can visit TeenHealthRx.com.

Are GLP-1 medications a quick fix for teenagers?

No.

GLP-1 medications can influence appetite regulation and weight management, but pediatric obesity is a chronic disease and treatment may be long term.

Doctors and researchers are continuing to study the long-term experience of children and adolescents using GLP-1 medications, including what happens when treatment is discontinued.

That uncertainty does not erase the benefits demonstrated in appropriately selected adolescents.

It does mean families should enter treatment understanding that medical obesity care may require continued follow-up, monitoring and long-term planning.

What should parents ask before considering a GLP-1 for their teen?

The first question probably should not be, "How fast will my child lose weight?"

Parents should understand why medication is being considered, which FDA-approved medication is being discussed, how eligibility is determined, which potential side effects deserve attention and how growth and progress will be monitored.

They should also ask how nutrition, movement, family support and ongoing follow-up fit into the treatment plan.

And the practical questions matter too: What does the consultation cost? What might medication cost? How often is follow-up needed? What happens if treatment needs to change?

Families who want those questions answered before deciding whether to proceed can schedule a free Discovery Call with California Trim Clinic.

What does TeenHealthRx offer families?

TeenHealthRx is California Trim Clinic's doctor-led medical weight-management pathway for adolescents ages 12-17.

Care can include virtual medical evaluation, individualized treatment planning, ongoing doctor-guided follow-up, family involvement and medication coordination when treatment is medically justified and legally permitted.

Families can begin by learning about the program and discussing current pricing through a complimentary Discovery Call.

Those ready for direct medical evaluation can book a $99 physician consultation with Dr. Lynda.

Booking a consultation does not guarantee medication or a prescription.

Frequently Asked Questions About GLP-1 Treatment for Teens

Can a 12-year-old take a GLP-1 medication for obesity?

Some adolescents ages 12 and older with obesity may qualify for FDA-approved treatment with Wegovy, or semaglutide.

FDA labeling applies to pediatric patients ages 12+ with obesity defined by BMI at or above the 95th percentile for age and sex. Eligibility still requires individualized medical review.

Is Wegovy FDA-approved for teenagers?

Yes.

Wegovy is FDA-approved for chronic weight management in pediatric patients ages 12 years and older with obesity when used alongside reduced-calorie nutrition and increased physical activity.

Are GLP-1 medications only for teenagers with diabetes?

No.

Wegovy's pediatric obesity indication does not require diabetes. A teenager can have obesity requiring medical treatment even when glucose or other metabolic measures appear normal.

Does every teenager who wants to lose weight qualify?

No.

FDA-approved pediatric Wegovy treatment is intended for adolescents ages 12+ with obesity, not simply any teenager seeking cosmetic weight loss.

Medical history, BMI percentile, contraindications, medications and individual health factors require doctor review.

Do GLP-1 medications replace healthy eating and exercise?

No.

Medication is used alongside nutrition, physical activity and other health behaviors rather than replacing them.

Will my teenager have to stay on a GLP-1 forever?

There is no single answer for every teenager.

Obesity is a chronic disease, and the appropriate duration of treatment depends on the individual patient's response, medical circumstances and ongoing doctor evaluation.

How can my family talk with California Trim Clinic about teen GLP-1 treatment?

Families can visit TeenHealthRx.com or schedule a free Discovery Call to ask about the program, pricing and next steps.

Families ready for physician evaluation can book the $99 consultation with Dr. Lynda Szczech.

A Teen's Life Is Bigger Than a Number on the Scale

Adam's story is compelling because the ending was not simply a lower BMI.

It was a teenager describing greater physical capability, joining a cheer team and feeling more confident participating in his own life.

No medication can promise that same experience for another teenager.

But stories like his show why families deserve access to the full medical conversation around adolescent obesity, including FDA-approved pharmacotherapy when it is medically indicated.

For families of teens ages 12-17, California Trim Clinic's TeenHealthRx pathway offers a doctor-led way to ask questions, understand available options and determine whether treatment deserves consideration.

Visit TeenHealthRx.com, schedule a free Discovery Call, or book a $99 physician consultation with Dr. Lynda.

California Trim Clinic
3717 E Thousand Oaks Blvd., Ste. 170
Westlake Village, CA 91362
805-892-8077

Medical Disclaimer

This press release is for educational and informational purposes only and does not constitute medical advice, diagnosis or treatment.

GLP-1 medications are not appropriate for every adolescent. Eligibility depends on age, BMI criteria, medical history, medication-specific indications, contraindications and individualized doctor review.

Wegovy is FDA-approved for chronic weight management in pediatric patients ages 12 years and older with obesity when used alongside reduced-calorie nutrition and increased physical activity.

Results vary. California Trim Clinic does not guarantee a particular amount of weight loss, BMI reduction, improvement in confidence, athletic performance or another treatment outcome.

Treatment requires individualized evaluation by a licensed doctor and is available only when medically justified and legally permitted.

Original Press Release.